Not applicableStudy completedNCT05572450What this trial is testingDose, Safety, and Pathogenicity of a New Influenza H1N1 Challenge StrainWho this might be right forInfluenza A H1N1 Hvivo 70
Early research (Phase 1)Study completedNCT02709278What this trial is testingAerosol BCG Challenge Trial in Healthy UK AdultsWho this might be right forTuberculosis University of Oxford 46
Early research (Phase 1)Looking for participantsNCT07305207What this trial is testingEstablishing a Controlled Human Infection Model for Influenza H3N2 as a Foundation for Pandemic PreparednessWho this might be right forInfluenza (Healthy Volunteers) Dalhousie University 32
Early research (Phase 1)Looking for participantsNCT06827470What this trial is testingEstablishing a Controlled Human Infection Model of Pertactin-deficient Bordetella PertussisWho this might be right forPertussis (Whooping Cough) Dalhousie University 60
Early research (Phase 1)Study completedNCT05136599What this trial is testingEstablishing a Controlled Human Infection Model of Bordetella PertussisWho this might be right forPertussis Dalhousie University 79
Early research (Phase 1)Study completedNCT05592223What this trial is testingPhase I Open Label BCG Clinical Trial Assessing TB Drugs and VaccinesWho this might be right forTuberculosis Fred Hutchinson Cancer Center 20
Early research (Phase 1)Study completedNCT02859350What this trial is testingSafety, Tolerability and Immunogenicity of PfSPZ Vaccine in an Age De-escalation Trial in Equatorial Guinea.Who this might be right forMalaria Sanaria Inc. 135
Early research (Phase 1)Looking for participantsNCT07706686What this trial is testingPhase 1 Challenge Study Using rDEN2delta30-7169 to Evaluate Host-Pathogen Interactions in Primary, Homotypic, and Heterotypic Dengue Virus InfectionWho this might be right forHealthy VolunteersDengueHuman Challenge Trial National Institute of Allergy and Infectious Diseases (NIAID) 200
Early research (Phase 1)Study completedNCT01868464What this trial is testingChallenge Model for Assessment of Human TB ImmunityWho this might be right forTuberculosis National Institute of Allergy and Infectious Diseases (NIAID) 92
Early research (Phase 1)WithdrawnNCT07124156What this trial is testingA Challenge Study to Assess the Blood-stage Efficacy of Full-length SUM-101 Malaria Vaccine CandidateWho this might be right forMalaria Fever European Vaccine Initiative
Testing effectiveness (Phase 2)Looking for participantsNCT07488897What this trial is testingRIG 101 Trial in Healthy Adults and Adults With AsthmaWho this might be right forHealthy Adult ParticipantsAsthma ExacerbationSafety and Efficacy RIGImmune Inc. 82
Not applicableStudy completedNCT06613737What this trial is testingDose, Safety, and Pathogenicity of a New Influenza A H3N2 Challenge StrainWho this might be right forInfluenza A H3N2 Hvivo 33
Early research (Phase 1)Study completedNCT04786457What this trial is testingADVP005; Dengue CVD 12000 - Dengue-1-Virus Live Virus Human Challenge (DENV-1-LVHC)Who this might be right forDengue University of Maryland, Baltimore 10
Not applicableStudy completedNCT00674336What this trial is testingInfectivity of Norovirus in Shellfish Treated With High Hydrostatic Pressure Processing-Human Challenge StudyWho this might be right forHealthy Emory University 51
Early research (Phase 1)Study completedNCT01226758What this trial is testingInfluenza Vaccine Challenge Study in Healthy SubjectsWho this might be right forInfluenza PepTcell Limited 32
Testing effectiveness (Phase 2)Study completedNCT02601716What this trial is testingPfSPZ Vaccine: Dose Optimization With Heterologous Challenge in Healthy Malaria-Naïve AdultsWho this might be right forMalaria Sanaria Inc. 92
Early research (Phase 1)Not Yet RecruitingNCT07730177What this trial is testingChallenge Trial of PfSPZ-LARC2 Vaccine in Burkina FasoWho this might be right forMalaria (Plasmodium Falciparum) Sanaria Inc. 45
Not applicableActive Not RecruitingNCT06670755What this trial is testingID93/GLA-SE Vaccination + BCG ChallengeWho this might be right forTuberculosis University of Oxford 48
Post-approval studies (Phase 4)Looking for participantsNCT06731374What this trial is testingCarriage to Assess Protection of New Pneumococcal Vaccines - PCV15Who this might be right forPneumococcal DiseasePneumococcal Carriage University of Oxford 106
Early research (Phase 1)Study completedNCT03261401What this trial is testingFirst-in-Human Trial of Single Ascending Dose, Multiple Ascending Dose and Malaria Challenge Model in Healthy ParticipantsWho this might be right forHealthy Merck KGaA, Darmstadt, Germany 88